Literature DB >> 9795066

Binding kinetics of budesonide to the human glucocorticoid receptor.

N Esmailpour1, P Högger, P Rohdewald.   

Abstract

Glucocorticoid receptor-ligand binding kinetics of budesonide, a glucocorticoid used for inhalation therapy, were determined and compared with dexamethasone and fluticasone propionate using glucocorticoid receptors from human lung tissue. From the association constant of 18.9 x 10(5)l mol-1 min-1 and the dissociation constant of 25.0 x 10(-4) min-1 resulted the equilibrium dissociation constant KD of 1.32 nmol/l and a relative receptor affinity of 855 with dexamethasone as reference (100). The half-life of the budesonide-receptor complex was 4.6 h. Results agree with data derived from competition tests we performed earlier.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795066     DOI: 10.1016/s0928-0987(97)00082-1

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  11 in total

1.  Surfactant plus budesonide decreases lung and systemic responses to injurious ventilation in preterm sheep.

Authors:  Noah H Hillman; T Brett Kothe; Augusto F Schmidt; Matthew W Kemp; Emily Royse; Erin Fee; Fabrizio Salomone; Michael W Clarke; Gabrielle C Musk; Alan H Jobe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-16       Impact factor: 5.464

2.  Synthesis and structure-activity relationships of novel cationic lipids with anti-inflammatory and antimicrobial activities.

Authors:  Melissa Myint; Robert Bucki; Paul A Janmey; Scott L Diamond
Journal:  Bioorg Med Chem Lett       Date:  2015-05-11       Impact factor: 2.823

3.  Glucocorticoid Cell Priming Enhances Transfection Outcomes in Adult Human Mesenchymal Stem Cells.

Authors:  Abby M Kelly; Sarah A Plautz; Janos Zempleni; Angela K Pannier
Journal:  Mol Ther       Date:  2015-10-19       Impact factor: 11.454

4.  Surfactant plus budesonide decreases lung and systemic inflammation in mechanically ventilated preterm sheep.

Authors:  T Brett Kothe; Matthew W Kemp; Augusto Schmidt; Emily Royse; Fabrizio Salomone; Michael W Clarke; Gabrielle C Musk; Alan H Jobe; Noah H Hillman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-06       Impact factor: 5.464

5.  Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor.

Authors:  D Jung; A C Fantin; U Scheurer; M Fried; G A Kullak-Ublick
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

6.  Presumed adrenal insufficiency in neonates treated with corticosteroids for the prevention of bronchopulmonary dysplasia.

Authors:  Justin B Josephsen; Brianna M Hemmann; Connie D Anderson; Brett M Hemmann; Paula M Buchanan; Howard L Williams; Lisa M Lubsch; Noah H Hillman
Journal:  J Perinatol       Date:  2021-11-01       Impact factor: 2.521

7.  Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis.

Authors:  Gary R Lichtenstein; Simon Travis; Silvio Danese; Geert D'Haens; Luigi Moro; Richard Jones; Michael Huang; E David Ballard; Robert Bagin; Yun Hardiman; Raul Collazo; William J Sandborn
Journal:  J Crohns Colitis       Date:  2015-06-20       Impact factor: 9.071

8.  Synthesis of budesonide conjugates and their anti-inflammatory effects: a preliminary study.

Authors:  Yan Yan; Pengchong Wang; Ruiying Li; Ying Sun; Rui Zhang; Chuanchuan Huo; Jianfeng Xing; Yalin Dong
Journal:  Drug Des Devel Ther       Date:  2019-02-19       Impact factor: 4.162

Review 9.  Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis.

Authors:  Gary R Lichtenstein
Journal:  Dig Dis Sci       Date:  2015-11-05       Impact factor: 3.199

10.  Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids.

Authors:  Maarten van den Berge; Jan De Backer; Cedric Van Holsbeke; Wilfried De Backer; Roopa Trivedi; Martin Jenkins; Paul Dorinsky; Magnus Aurivillius
Journal:  Respir Res       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.